Higher than recommended amikacin loading doses achieve pharmacokinetic targets without associated toxicity

Clicks: 205
ID: 269109
2011
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Antibiotic therapy improves the outcome of severe sepsis and septic shock, however pharmacokinetic properties are altered in this scenario. Amikacin (AMK) is an option to treat community or nosocomial infections, although standard doses might be insufficient in critically ill patients. The aim of th …
Reference Key
r2011internationalhigher Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Gálvez R;Luengo C;Cornejo R;Kosche J;Romero C;Tobar E;Illanes V;Llanos O;Castro J;;
Journal international journal of antimicrobial agents
Year 2011
DOI
DOI not found
URL
https://www.ncbi.nlm.nih.gov/pubmed/21612894
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine female male aged middle aged Randomized Controlled Trial sepsis / drug therapy* anti-bacterial agents / administration & dosage* anti-bacterial agents / pharmacokinetics amikacin / adverse effects* anti-bacterial agents / adverse effects* amikacin / administration & dosage* kidney function tests pmid:21612894 doi:10.1016/j.ijantimicag.2011.03.022 ricardo gálvez cecilia luengo josé castro amikacin / pharmacokinetics creatinine / metabolism metabolic clearance rate plasma / chemistry*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.